Optimised cell culture development for pharma, biotech, CMOs and media providers
Dr Ulrich Göpfert | Senior Scientist, Pharma Research and Early Developent Roche Pharmaceuticals
Ulrich Göpfert is a Senior Reseach Scientist in the Cell Line and Molecule Development department at Roche. Dr. Göpfert received his Diploma and Ph.D. in Biochemistry from the University of Tübingen, Germany. In 2002 he joined the Biologics Research group of Roche in Penzberg. Since then he has been involved in the pre-clinical development of numerous therapeutic antibodies with a focus on lead identification, optimization and cell line development. His special interest is in the optimization of cell line selection processes for clinical supply and manufacturing.
Share this
Appearances at this years' conference:
DAY 2 - Wednesday 29th February 2012
@ 09.10
Development of an early warning system for production instability
How important is the early identification of the instability of specific cell lines in terms of reducing production times and costs?
Exploring a new real-time qPCR which can deliver fast and sensitive measurements in multiple cell lines; effectively acting as an early warning system for production instability
Will this early identification lead to other beneficial outcomes? Will it result in better clones in terms of bioprocess robustness and productivity?
› Dr Ulrich Göpfert, Senior Scientist, Pharma Research and Early Developent, Roche Pharmaceuticals